NEIL BAUTISTA: Open Payments
NPI 1275110280 · FALLS CHURCH, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$372 in 17 payments from 13 companies in 2025. Trend: 2023 $261 · 2024 $186 · 2025 $372
Food & beverage: $372
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 2 | $44 |
| Novo Nordisk Inc | 2 | $41 |
| E.R. Squibb & Sons, L.L.C. | 2 | $39 |
| Esperion Therapeutics, Inc. | 2 | $35 |
| Kestra Medical Technology Services, Inc. | 1 | $30 |
| BridgeBio Pharma, Inc. | 1 | $27 |
| SCPHARMACEUTICALS INC. | 1 | $26 |
| Cleerly, Inc. | 1 | $26 |
| Recor Medical Inc | 1 | $26 |
| Merck Sharp & Dohme LLC | 1 | $23 |
Products named: Wegovy, ELIQUIS, NEXLETOL, Assure WCD, Attruby, FUROSCIX, Cleerly Ischemia, Paradise Ultrasound Renal Denervation System.
Industry payments across VA — which companies pay providers there.
